EntryPoint Capital’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
FLSM
JT
EntryPoint Capital's MIRM Position: Q2 2026 in Review
EntryPoint Capital held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 5,150 shares worth $603K. The position accounts for 0.15% of the portfolio, ranked #249.
EntryPoint Capital first reported a position in MIRM in Q4 2023 and has held it in 9 quarters since. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.
- EntryPoint Capital held 5,150 shares of Mirum Pharmaceuticals worth $603K as of Q2 2026.
- EntryPoint Capital left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
- Mirum Pharmaceuticals made up 0.15% of EntryPoint Capital's portfolio in Q2 2026, its #249 holding.
- EntryPoint Capital first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
- 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.